P02.04 Tumor treating fields induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy

Ítems similars

• IMMU-52. TUMOR TREATING FIELDS (TTFIELDS) INDUCE IMMUNOGENIC CELL DEATH RESULTING IN ENHANCED ANTITUMOR EFFICACY WHEN COMBINED WITH ANTI-PD-1 THERAPY
  per: Voloshin, Tali, et al.
  Publicat: (2018)
• IMMU-59. ALTERNATING ELECTRIC FIELDS (TTFIELDs) INDUCE IMMUNOGENIC CELL DEATH RESULTING IN ENHANCED ANTITUMOR EFFICACY WHEN COMBINED WITH ANTI-PD-1 THERAPY
  per: Voloshin, Tali, et al.
  Publicat: (2017)
• Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
  per: Voloshin, Tali, et al.
  Publicat: (2020)
• P04.16 Tumor treating fields affect invasion properties and cell morphology of various cancer cells
  per: Schneiderman, R, et al.
  Publicat: (2018)
• P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling
  per: Porat, Y, et al.
  Publicat: (2018)